Skip to content
HowShorted

Corvus Pharmaceuticals, Inc. short interest in 2023

In 2023, Corvus Pharmaceuticals, Inc.'s disclosed short interest ran from 0.37% of shares outstanding on 13 Jan 2023 to 2.72% on 29 Dec 2023, a change of +2.35 percentage points. The year's high was 3.72% on 15 Sep 2023 and its low 0.24% on 31 Jan 2023, averaging 1.92% across 18 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.55 days on 13 Oct 2023. Full history: Corvus Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Corvus Pharmaceuticals, Inc. in 2023

2023 in figures

Start of year
0.37% (13 Jan 2023)
End of year
2.72% (29 Dec 2023)
Change
+2.35 pp
High
3.72% (15 Sep 2023)
Low
0.24% (31 Jan 2023)
Average
1.92%
Highest days to cover
16.55 (13 Oct 2023)
SEC filings marked
8

Every report in 2023

Corvus Pharmaceuticals, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20230.37%1.44
31 Jan 20230.24%1.00
15 Feb 20230.27%1.66
28 Feb 20230.37%1.93
15 Mar 20230.43%1.97
31 Mar 20230.34%1.0010-K filed, results (8-K)
14 Apr 20230.51%1.00
28 Apr 20230.32%1.00
15 Aug 20232.31%6.0710-Q filed, results (8-K), 10-Q filed, results (8-K)
31 Aug 20232.80%4.22
15 Sep 20233.72%3.27
29 Sep 20233.62%10.02
13 Oct 20233.62%16.55
31 Oct 20233.50%11.91
15 Nov 20233.65%4.8110-Q filed, results (8-K)
30 Nov 20233.20%12.17
15 Dec 20232.66%4.93
29 Dec 20232.72%6.99

See also: Corvus Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.